Anticorps Monoclonal anti-CD34

CD34 Monoclonal Antibody for WB, IHC, IF-P, ELISA

Hôte / Isotype

Mouse / IgG2b

Réactivité testée

Humain

Applications

WB, IHC, IF-P, ELISA

Conjugaison

Non conjugué

Publications(1)

CloneNo.

3C8G12

N° de cat : 60180-1-PBS

Synonymes

3C8G12, CD34 molecule



Applications publiées

IFSee 1 publications below

Informations sur le produit

60180-1-PBS cible CD34 dans les applications de WB, IHC, IF-P, ELISA et montre une réactivité avec des échantillons Humain

Réactivité Humain
Réactivité citéeHumain
Hôte / Isotype Mouse / IgG2b
Clonalité Monoclonal
Type Anticorps
Immunogène CD34 Protéine recombinante Ag5996
Nom complet CD34 molecule
Masse moléculaire calculée 41 kDa
Poids moléculaire observé 105 kDa
Numéro d’acquisition GenBankBC039146
Symbole du gène CD34
Identification du gène (NCBI) 947
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

CD34 is a 105- to 120-kDa glycophosphoprotein expressed on the majority of hematopoietic stem/progenitor cells, bone marrow stromal cells, capillary endothelial cells, embryonic fibroblasts, and some nerve tissue. CD34 is a commonly used marker for identifying human hematopoietic stem/progenitor cells and mediates cell adhesion and lymphocyte homing by binding L-selectin and E-selectin ligands. CD34 is also one of the best negative selection markers for characterizing and/or isolating human MSCs from bone marrow and other sources. Along with other positive selection markers (such as CD29, CD44, CD90, CD105 and CD166), negative selection markers (such as CD34 and CD45) are used for MSC identification. The calculated molecular mass of human CD34 is 41 kDa, various forms with different molecular weights may be produced due to different glycosylation patterns and alternative splicing (PMID: 24375067; 15750786).

Publications

SpeciesApplicationTitle
humanIF

Acta Pharmacol Sin

Genetic and pharmacological targeting of Snail inhibits atherosclerosis by relieving intraplaque endothelium dysfunction and associated inflammation

Authors - Bo-Xue Ren
{{ptg:RelatedPrimaryAntibodies}}